期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
A mitochondria-targeted H_(2)S-activatable fluorogenic probe for tracking hepatic ischemia-reperfusion injury
1
作者 Bin Fang Jiaqi Yang +10 位作者 Limin Wang Haoqin Li Jiaying Guo Jiaxin Zhang Qingyuan Guo Bo Peng Kedi Liu Miaomiao Xi Hua Bai Li Fu Lin Li 《Chinese Chemical Letters》 SCIE CAS CSCD 2024年第6期370-375,共6页
Hepatic ischemia-reperfusion injury(HIRI)is the cause of postoperative hepatic dysfunction and failure,and even death.As an important biological effector molecule,hydrogen sulfide(H_(2)S)of mitochondria as a gasotrans... Hepatic ischemia-reperfusion injury(HIRI)is the cause of postoperative hepatic dysfunction and failure,and even death.As an important biological effector molecule,hydrogen sulfide(H_(2)S)of mitochondria as a gasotransmitter that is usually used to protect against acute HIRI injury.However,the exact relationship between HIRI and mitochondrial H_(2)S remains tangled due to the lack of an effective analytical method.Herein,we have fabricated a mitochondria-targeted H_(2)S-activatable fluorogenic probe(Mito-GW)to explore the stability of mitochondrial H_(2)S and track the changes of mitochondrial H_(2)S during the HIRI.By virtue of pyridinium electropositivity and its amphiphilicity,Mito-GW could accumulate in mitochondria.It goes through an analyte-prompted immolation when reacts with H_(2)S,resulting in the releasing of the fluorophore(GW).Therefore,the extent of Mito-GW conversion to GW can be used to evaluate the changes of mitochondrial H_(2)S level in living cells and tissues.As proof-of-principle,we have used MitoGW to demonstrate the mitochondria H_(2)S-levels increase and then decrease during HIRI in vitro and in vivo.Our research highlights the tremendous potential of Mito-GW as a mitochondrial H_(2)S fluorogenic probe in elucidating the pathogenesis of HIRI,providing a powerful tool for promoting future research on hepatology. 展开更多
关键词 Mitochondria-targeted Bioimaging H2S-activatable Fluorogenic probe Hepatic ischemia-reperfusion injury(hiri)
原文传递
Key role of interferon regulatory factor 1(IRF-1)in regulating liver disease:progress and outlook
2
作者 Tao CHEN Shipeng LI +3 位作者 Dewen DENG Weiye ZHANG Jianjun ZHANG Zhongyang SHEN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2024年第6期451-470,共20页
Interferon regulatory factor 1(IRF-1)is a member of the IRF family.It is the first transcription factor to be identified that could bind to the interferon-stimulated response element(ISRE)on the target gene and displa... Interferon regulatory factor 1(IRF-1)is a member of the IRF family.It is the first transcription factor to be identified that could bind to the interferon-stimulated response element(ISRE)on the target gene and displays crucial roles in the interferoninduced signals and pathways.IRF-1,as an important medium,has all of the advantages of full cell cycle regulation,cell death signaling transduction,and reinforcing immune surveillance,which are well documented.Current studies indicate that IRF-1 is of vital importance to the occurrence and evolution of multifarious liver diseases,including but not limited to inhibiting the replication of the hepatitis virus(A/B/C/E),alleviating the progression of liver fibrosis,and aggravating hepatic ischemiareperfusion injury(HIRI).The tumor suppression of IRF-1 is related to the clinical characteristics of liver cancer patients,which makes it a potential indicator for predicting the prognosis and recurrence of liver cancer;additionally,the latest studies have revealed other effects of IRF-1 such as protection against alcoholic/non-alcoholic fatty liver disease(AFLD/NAFLD),cholangiocarcinoma suppression,and uncommon traits in other liver diseases that had previously received little attention.Intriguingly,several compounds and drugs have featured a protective function in specific liver disease models in which there is significant involvement of the IRF-1 signal.In this paper,we hope to propose a prospective research basis upon which to help decipher translational medicine applications of IRF-1 in liver disease treatment. 展开更多
关键词 Interferon regulatory factor(IRF-1) Hepatitis virus Liver fibrosis Hepatic ischemia-reperfusion injury(hiri) Liver cancer
原文传递
Endothelial Notch activation promotes neutrophil transmigration via downregulating endomucin to aggravate hepatic ischemia/reperfusion injury 被引量:2
3
作者 Peiran Zhang Kangyi Yue +9 位作者 Xinli Liu Xianchun Yan Ziyan Yang Juanli Duan Congcong Xia Xinyuan Xu Mei Zhang Liang Liang Lin Wang Hua Han 《Science China(Life Sciences)》 SCIE CAS CSCD 2020年第3期375-387,共13页
Inflammatory leukocytes infiltration is orchestrated by mechanisms involving chemokines,selectins,addressins and other adhesion molecules derived from endothelial cells(ECs),but how they respond to inflammatory cues a... Inflammatory leukocytes infiltration is orchestrated by mechanisms involving chemokines,selectins,addressins and other adhesion molecules derived from endothelial cells(ECs),but how they respond to inflammatory cues and coordinate leukocyte transmigration remain elusive.In this study,using hepatic ischemia/reperfusion injury(HIRI)as a model,we identified that endothelial Notch activation was rapidly and dynamically induced in liver sinusoidal endothelial cells(LSECs)in acute inflammation.In mice with EC-specific Notch activation(NICeCA),HIRI induced exacerbated liver damage.Consistently,endothelial Notch activation enhanced neutrophil infiltration and tumor necrosis factor(TNF)-αexpression in HIRI.Transcriptome analysis and further qRT-PCR as well as immunofluorescence indicated that endomucin(EMCN),a negative regulator of leukocyte adhesion,was downregulated in LSECs from NICeCA mice.EMCN was downregulated during HIRI in wild-type mice and in vitro cultured ECs insulted by hypoxia/re-oxygenation injury.Notch activation in ECs led to increased neutrophil adhesion and transendothelial migration,which was abrogated by EMCN overexpression in vitro.In mice deficient of RBPj,the integrative transcription factor of canonical Notch signaling,although overwhelming sinusoidal malformation aggravated HIRI,the expression of EMCN was upregulated;and pharmaceutical Notch blockade in vitro also upregulated EMCN and inhibited transendothelial migration of neutrophils.The Notch activation-exaggerated HIRI was compromised by blocking LFA-1,which mediated leukocyte adherence by associating with EMCN.Therefore,endothelial Notch signaling controls neutrophil transmigration via EMCN to modulate acute inflammation in HIRI. 展开更多
关键词 LEUKOCYTE transendothelial migration HEPATIC ISCHEMIA/REPERFUSION injury(hiri) liver sinusoidal ENDOTHELIAL cells(LSECs) Notch endomucin(EMCN)
原文传递
山药多糖对小鼠肝缺血再灌注损伤中的肝脾组织的保护作用 被引量:10
4
作者 宋俊杰 陈英 +4 位作者 范军朝 王丹丹 毛珊珊 郑孝振 王莹 《实用医药杂志》 2018年第4期343-346,共4页
目的探究山药多糖对小鼠肝缺血再灌注损伤肝脾组织的影响。方法 SPF级KM小鼠32只,随机分为对照组(C组);盐水+肝缺血再灌注损伤组(N组);山药多糖中剂量+肝缺血再灌注损伤组(M组);山药多糖高剂量+肝脏缺血再灌注损伤组(H组),每组8只。山... 目的探究山药多糖对小鼠肝缺血再灌注损伤肝脾组织的影响。方法 SPF级KM小鼠32只,随机分为对照组(C组);盐水+肝缺血再灌注损伤组(N组);山药多糖中剂量+肝缺血再灌注损伤组(M组);山药多糖高剂量+肝脏缺血再灌注损伤组(H组),每组8只。山药多糖中剂量为60 mg/kg,高剂量为120 mg/kg。在缺血再灌注模型制作前分别给予不同剂量的山药多糖灌胃,1次/d,共14 d,正常对照组和盐水组则给予等容量的生理盐水。再灌注24 h后,处死全部小鼠,测定脾指数和肝指数,苏木精-伊红(HE)染色观察小鼠肝和脾组织病理学改变。结果与N组相比,M组及H组的肝指数降低(P<0.05)。与N组相比,M及H组的肝组织病理学损伤轻微,且病理学评分降低(P<0.05)。与C组相比,N组的脾指数增高(P<0.05),与N组相比,M组和H组的脾指数降低,且M组的降低较明显(P<0.05)。与N组相比,M组及H组脾组织病理学的损伤减轻。结论中剂量及高剂量的山药多糖对肝缺血再灌注损伤中的肝和脾组织损伤有保护作用。 展开更多
关键词 山药多糖 肝缺血再灌注损伤 肝指数 脾指数
下载PDF
羌活醇提取物对肝缺血再灌注损伤大鼠肝组织抗氧化酶的影响 被引量:10
5
作者 俞科贤 李福安 +3 位作者 魏全嘉 李永平 王生兰 刘占厚 《中医杂志》 CSCD 北大核心 2011年第13期1135-1137,1140,共4页
目的探讨羌活醇提取物对肝缺血再灌注损伤(HIRI)大鼠模型抗氧化作用的影响及机制。方法将100只大鼠随机分为空白组、模型组、丹参预处理组(DS组)和羌活预处理组(QH组)4组,后3组组内再分为缺血45min(I45)和缺血45min再灌注30min(I45R30)... 目的探讨羌活醇提取物对肝缺血再灌注损伤(HIRI)大鼠模型抗氧化作用的影响及机制。方法将100只大鼠随机分为空白组、模型组、丹参预处理组(DS组)和羌活预处理组(QH组)4组,后3组组内再分为缺血45min(I45)和缺血45min再灌注30min(I45R30)、缺血45min再灌注60min(I45R60)3个时间点,DS组、QH组分别给予丹参醇提取物、羌活醇提取物灌胃,均1ml/d,连续7d。行HIRI造模后分别测定各组大鼠各时点即刻血清丙氨酸氨基转移酶(ALT)水平和肝组织丙二醛(MDA)含量和谷胱甘肽过氧化物酶(GSH-Px)活力水平。结果模型组、QH组和DS组内大鼠模型I45R30、I45R60时点的血清ALT水平、MDA含量、GSH-Px活力均较I45时点明显升高(P<0.01);DS组I45R60时点大鼠肝组织中MDA含量较QH组明显降低(P<0.05);DS组I45R60时点大鼠肝组织GSH-Px活力均较模型组和QH组低(P<0.05)。结论羌活醇提取物可能是通过提高HIRI模型大鼠肝组织GSH-Px活力,增强对氧自由基的清除能力,减轻脂质过氧化损伤,从而起到保护肝脏的作用。 展开更多
关键词 羌活 肝缺血再灌注损伤 丙二醛 谷胱甘肽过氧化酶
原文传递
七氟醚通过STING/AMPK信号通路减轻小鼠肝脏缺血再灌注损伤的研究
6
作者 张海霞 程志军 +1 位作者 李辉 季惠 《生命科学研究》 CAS 2024年第3期206-214,共9页
为探讨七氟醚(sevoflurane)麻醉处理对小鼠肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury, HIRI)的影响及机制,将健康成年C57雄性小鼠随机分为假手术组(Sham组)、缺血再灌注+戊巴比妥钠组(HIRI+Pent组)、缺血再灌注+七氟醚组... 为探讨七氟醚(sevoflurane)麻醉处理对小鼠肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury, HIRI)的影响及机制,将健康成年C57雄性小鼠随机分为假手术组(Sham组)、缺血再灌注+戊巴比妥钠组(HIRI+Pent组)、缺血再灌注+七氟醚组(HIRI+Sevo组),每组10只;经腹腔手术构建小鼠70%肝脏HIRI模型,肝脏缺血60 min,再灌注3 h后,将小鼠处死取材。取肝组织行苏木精-伊红(hematoxylin-eosin, HE)染色,观察肝组织病理损伤,同时采用免疫荧光染色检测髓过氧化物酶(myeloperoxidase, MPO)含量,并采用TUNEL检测组织细胞凋亡;通过酶联免疫吸附测定(enzyme-linked immunosorbent assay, ELISA)、聚合酶链反应(polymerase chain reaction, PCR)检测肝组织炎症相关因子的表达;通过Western-blot检测肝组织干扰素基因刺激因子(stimulator of interferon genes, STING)、AMP活化蛋白激酶(AMP-activated protein kinase, AMPK)等相关蛋白质的表达;采用生化分析仪检测血清丙氨酸转氨酶(alanine transaminase, ALT)、天冬氨酸转氨酶(aspartate transaminase, AST)和乳酸脱氢酶(lactate dehydrogenase, LDH)水平;分别采用硫代巴比妥酸(thiobarbituric acid, TBA)比色法、黄嘌呤氧化酶法及二硫代二硝基苯甲酸法测定还原型谷胱甘肽(glutathione, GSH)、脂质过氧化物丙二醛(malondialdehyde, MDA)和超氧化物歧化酶(superoxide dismutase, SOD)含量。结果显示,与Sham组比较,缺血再灌注后,HIRI+Pent组小鼠血清ALT、AST明显升高,肝脏组织可观察到大片梗死区域,细胞凋亡明显增加, STING、核因子κB (nuclear factor-κB, NF-κB)表达升高,同时AMPK下降明显,炎症因子肿瘤坏死因子-α (tumor necrosis factor-α, TNF-α)、白细胞介素(interleukin, IL)-1β、IL-6、IL-18明显升高, MPO表达明显增加,氧化应激标志物GSH、MDA及SOD水平均出现明显差异,而在HIRI+Sevo组中,上述变化程度均得到明显缓解,且差异具有统计显著性(P<0.05)。结果表明,七氟醚可� 展开更多
关键词 七氟醚 肝脏缺血再灌注损伤(hiri) 干扰素基因刺激因子(STING) AMP活化蛋白激酶(AMPK)
下载PDF
线粒体自噬在肝脏缺血再灌注损伤中的作用 被引量:1
7
作者 张祥鑫 李文 《基础医学与临床》 CAS 2024年第6期877-881,共5页
肝脏缺血再灌注损伤(HIRI)时,线粒体自噬可通过PINK1-Parkin、线粒体自噬受体等途径激活,并与线粒体动态平衡调节蛋白的表达密切相关。线粒体自噬是一把双刃剑,适度的线粒体自噬通过减轻氧化应激和维持线粒体稳态,起到减少肝细胞凋亡和... 肝脏缺血再灌注损伤(HIRI)时,线粒体自噬可通过PINK1-Parkin、线粒体自噬受体等途径激活,并与线粒体动态平衡调节蛋白的表达密切相关。线粒体自噬是一把双刃剑,适度的线粒体自噬通过减轻氧化应激和维持线粒体稳态,起到减少肝细胞凋亡和坏死,抑制炎性反应,减轻HIRI的作用;而过度的线粒体自噬会加重HIRI。了解HIRI中线粒体自噬的调节机制和作用将为HIRI的防治提供新策略。 展开更多
关键词 肝脏缺血再灌注损伤 线粒体自噬 线粒体动态调节蛋白
下载PDF
人骨髓间充质干细胞及其外泌体在肝移植术后肝缺血再灌注损伤中潜在治疗作用的研究进展
8
作者 张奕涵 姚伟锋 《中国临床新医学》 2024年第4期384-388,共5页
肝缺血再灌注损伤(HIRI)是传统肝移植术中不可避免的病理生理过程,其严重程度受到来自供体和受体的多方面因素影响,最严重者可导致术后早期移植肝无功能。人骨髓间充质干细胞(BMSCs)及其外泌体已在临床试验中被证实具有促进组织修复与... 肝缺血再灌注损伤(HIRI)是传统肝移植术中不可避免的病理生理过程,其严重程度受到来自供体和受体的多方面因素影响,最严重者可导致术后早期移植肝无功能。人骨髓间充质干细胞(BMSCs)及其外泌体已在临床试验中被证实具有促进组织修复与免疫调节的能力,这一治疗作用在HIRI的防治中具有较好的应用前景。该文旨在综述BMSCs及其外泌体在移植肝HIRI防治中潜在作用机制的研究进展及未来研究方向。 展开更多
关键词 肝缺血再灌注损伤 肝移植 人骨髓间充质干细胞 外泌体
下载PDF
重组促红细胞生成素对脂肪肝缺血再灌注损伤大鼠细胞凋亡和炎症因子的影响 被引量:1
9
作者 常顺伍 韩晓玉 +1 位作者 宫晓光 王葆春 《海南医学》 CAS 2020年第14期1769-1773,共5页
目的探讨重组促红细胞生成素(rHuEPO)对脂肪肝缺血再灌注损伤(HIRI)大鼠细胞凋亡和炎症因子的影响。方法高脂饲料饲养的无特定病原体(SPF)雄性SD大鼠90只,造模成功后,采用随机数表法分为假手术组、模型组和rHuEPO组,每组30只,rHuEPO组... 目的探讨重组促红细胞生成素(rHuEPO)对脂肪肝缺血再灌注损伤(HIRI)大鼠细胞凋亡和炎症因子的影响。方法高脂饲料饲养的无特定病原体(SPF)雄性SD大鼠90只,造模成功后,采用随机数表法分为假手术组、模型组和rHuEPO组,每组30只,rHuEPO组于缺血前24 h时腹腔注射rHuEPO 4000 IU/kg,假手术组和模型组腹腔注射等容量的生理盐水,再灌注后1 h、3 h和6 h的采集血液及肝组织标本,比较各组大鼠肝细胞凋亡指数、血浆肿瘤坏死因子-α(TNF-α)和白细胞介素-1(IL-1)、血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)、肝组织丙二醛(MDA)和超氧化物歧化酶(SOD)水平。结果病理观察显示:HIRI后模型组、rHuEPO组大鼠肝组织结构改变,其中模型组改变更为明显;假手术组、模型组和rHuEPO组大鼠再灌注1 h的细胞凋亡指数分别为(3.28±0.63)%、(27.86±2.87)%、(21.38±2.62)%,差异有统计学意义(P<0.05);三组大鼠再灌注3 h的细胞凋亡指数分别为(3.56±0.83)%、(37.24±3.65)%、(28.65±2.74)%,再灌注6 h的细胞凋亡指数分别为(3.41±0.72)%、(46.92±3.88)%、(32.44±3.07)%,差异均有统计学意义(P<0.05);假手术组大鼠血清ALT及AST水平、血浆TNF-α及IL-1水平、肝组织MDA水平明显低于rHuEPO组和模型组,r HuEPO组明显低于模型组,差异均有统计学意义(P<0.05);模型组和rHuEPO组大鼠血清ALT及AST水平、血浆TNF-α及IL-1水平、肝组织MDA水平再灌注3 h组明显高于再灌注1 h组,再灌注6 h组高于再灌注3 h组,差异均有统计学意义(P<0.05);假手术组大鼠肝组织SOD再灌注1 h、3 h、6 h水平分别为(113.28±9.67)U/mg、(115.07±9.72)U/mg、(114.36±9.52)U/mg,模型组分别为(51.25±6.34)U/mg、(42.36±6.14)U/mg、(36.18±5.92)U/mg,rHuEPO组分别为(82.58±7.42)U/mg、(70.06±6.95)U/mg、(67.43±6.71)U/mg,假手术组水平明显高于rHuEPO组和模型组,rHuEPO组明显高于模型组,差异均有统计学意义(P<0.05);假手术组的不同� 展开更多
关键词 重组促红细胞生成素 缺血再灌注损伤 脂肪肝 大鼠 细胞凋亡 炎症因子
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部